Jorge presented findings from a study using data from the US multicenter electronic health record database TriNetX, showing that, among patients who had both T2D and SLE, those using GLP-1 RAs had lower risks for major adverse cardiac events (MACE), venous thrombosis, kidney disease progression, and all-cause mortality, compared with those using a different class of T2D medication
Mens resultaterne for eksempelvis Alzheimers har vret skuffende, mener han, at belnningssystemet og afhngighed er et af de mest lovende omrder for fremtidens brug af GLP-1
Your provider monitors progress and adjusts your protocol
Taking zinc on an empty stomach can cause stomach upset
Glutathione (600 ppm): acts as a biological filter, removing toxins and providing the face with unparalleled clarity
Lara holds ABOM certification with 30+ years treating metabolically complex patients